# adenosine

NDC: 67457-855
Generic name: adenosine
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20180508

FDA application: ANDA078686

## Active ingredients

- ADENOSINE: 3 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67457-855"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67457-855
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d2d06ee6-c89f-49f7-9e2c-46d33ce877a9